Identification of endothelin–1 in the pathophysiology of metastatic adenocarcinoma of the prostate (original) (raw)

• Wingo, P.A., Tong, T. & Bolden, S. Cancer statistics, 1995. CA Cancer J. Clin. 45, 8–30 (1995).
  Article CAS Google Scholar
• Huggins, C., Stevens, R.E. & Hodges, C.V. Studies on prostate cancer. II. The effects of castration on advanced carcinoma of the prostate gland. Arch. Surg. 43, 209–223 (1941).
  Article CAS Google Scholar
• Kelly, W.K. et al. Prostate-specific antigen as a measure of disease outcome in metastatic hormone-refractory prostate cancer. J. clin. Oncol. 11, 607–615 (1993).
  Article CAS Google Scholar
• Yanagisawa, M. et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332, 411–415 (1988).
  Article CAS Google Scholar
• Casey, M.L., Byrd, W. & MacDonald, P.C. Massive amounts of immunoreactive endothelin in human seminal fluid. J. clin. Endoc. Metabol. 74, 223–225 (1992).
  CAS Google Scholar
• Langenstroer, P. et al. Endothelin-1 in the human prostate: tissue levels, source of production and isometric tension studies. J. Urol. 149, 495–499 (1993).
  Article Google Scholar
• Kobayashi, S. et al. Binding and functional properties of endothelin receptor subtypes in the human prostate. Molec. Pharmacol. 45, 306–311 (1994).
  CAS Google Scholar
• Kobayashi, S. et al. Localization of endothelin receptors in the human prostate. J. Urol. 151, 763–766 (1994).
  Article CAS Google Scholar
• Muldoon, L.L., Rodland, K.D., Forsythe, M.L. & Magun, B.E. Stimulation of phosphatidylinositol hydrolysis, diacylglycerol release, and gene expression in response to endothelin, a potent new agonist for fibroblasts and smooth muscle cells. J. biol. Chem. 264, 8529–8536 (1989).
  CAS PubMed Google Scholar
• Brown, K.D. & Littlewood, C.J. Endothelin stimulates DNA synthesis in Swiss 3T3 cells: Synergy with polypeptide growth factors. Biochem. J. 263, 977–980 (1989).
  Article CAS Google Scholar
• Shubeita, H.E. et al. Endothelin induction of inositol phospholipid hydrolysis, sarcomere assembly and cardiac gene expression in ventricular myocytes. J. biol. Chem. 265, 20555–20562 (1990).
  CAS PubMed Google Scholar
• Battistini, B., Chailler, P., D'Orleans-Juste, P., Briere, N. & Sirois, P. Growth regulatory properties of endothelins. Peptides 14, 385–399 (1993).
  Article CAS Google Scholar
• Schirchiri, M. et al. Endothelin-1 is an autocrine/paracrine growth factor for human cancer cell lines. J. clin. Invest. 87, 1867–1871 (1991).
  Article Google Scholar
• Takuwa, Y., Ohue, Y., Takuwa, N. & Yamashita, K. Endothelin-1 activates phospholipase C and mobilizes Ca2+ from extra- and intracellular pools in osteoblastic cells. Am. J. Physiol. 257, E797–803 (1989).
  CAS PubMed Google Scholar
• Takuwa, Y., Masaki, T. & Yamashita, K. The effects of the endothelin family peptides on cultured osteoblastic cells from rat calvariae. Biochem. biophys. Res. Commun. 170, 998–1005 (1990).
  Article CAS Google Scholar
• Schvartz, I., Ittoop, O., Davidai, G. & Hazum, E. Endothelin rapidly stimulates tyrosine phosphorylation in osteoblast-like cells. Peptides 13, 159–163 (1992).
  Article CAS Google Scholar
• Shioide, M. & Noda, M. Endothelin modulates osteopontin and osteocalcin messenger ribonucleic acid expression in rat osteoblastic osteosarcoma cells. J. cell. Biochem. 53, 176–180 (1993).
  Article CAS Google Scholar
• Suzuki, N., Matsumoto, H., Kitada, C., Kimura, S. & Fujino, M. Production of endothelin-1 and big-endothelin-1 by tumour cells with epithelial-like morphology. J. Biochem. 106, 736–741 (1989).
  Article CAS Google Scholar
• Kusuhara, M. et al. Production of endothelin in human cancer cell lines. Cancer Res. 50, 3257–3261 (1990).
  CAS PubMed Google Scholar
• Schrey, M.P., Patel, K.V. & Tezapsidis, N. Bombesin and glucocorticoids stimulate human breast cancer cells to produce endothelin, a paracrine mitogen for breast stromal cells. Cancer Res. 52, 1786–1790 (1992).
  CAS PubMed Google Scholar
• Economos, K., MacDonald, P.C. & Casey, M.L. Endothelin-1 gene expression and biosynthesis in human endometrial HEC-1A cancer cells. Cancer Res. 52, 554–557 (1992).
  CAS PubMed Google Scholar
• Yamashita, J. et al. Abundant expression of immunoreactive endothelin-1 in mammary phyllodes tumour: Possible role of endothelin 1 in the growth of stromal cells in phyllodes tumour. Cancer Res. 52, 4046–4049 (1992).
  CAS PubMed Google Scholar
• Yamashita, J. et al. Interleukin 6 stimulates the production of immunoreactive endothelin 1 in human breast cancer cells. Cancer Res. 53, 464–467 (1993).
  CAS PubMed Google Scholar
• Inoue, A. et al. The human endothelin family: Three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc. natn. Acad. Sci. U.S.A. 86, 2863–2867 (1989).
  Article CAS Google Scholar
• Takasaki, C., Yanagisawa, M., Kimura, S., Goto, K. & Masaki, T. Similarity of endothelin to snake venom toxin. Nature 335, 303 (1988).
  Article Google Scholar
• Kochva, E., Bdolah, A. & Wollberg, Z. Sarafotoxins and endothelins: Evolution, structure and function. Toxicon 31, 541–568 (1993).
  Article CAS Google Scholar
• Kochva, E., Viljoen, C.C. & Botes, D.P. A new type of toxin in the venom of snakes of the genus Atractaspis (Atractaspidinae). Toxicon 20, 581–592 (1982).
  Article CAS Google Scholar
• Dahlof, B., Gustafsson, D., Hedner, T., Jern, S. & Hansson, L. Regional haemodynamic effects of endothelin-1 in rat and man: Unexpected adverse reactions. J. Hypertens. 8, 811–817 (1990).
  Article CAS Google Scholar
• Eisenberger, M.A. et al. Suramin, an active drug for prostate cancer: Interim observations in a phase I trial. J. natn. Cancer Inst. 85, 611–621 (1993).
  Article CAS Google Scholar
• Yamane, K. et al. Significance of plasma endothelin-1 levels in patients with systemic sclerosis. J. Rheumatol. 19, 1566–1571 (1992).
  CAS PubMed Google Scholar
• Ogawa, S., Zhang, J. & Yuge, K. Increased plasma endothelin-1 concentration in Kawasaki disease. J. Cardiovasc. Pharmacol. 22, S364–366 (1993).
  Article CAS Google Scholar
• Cernacek, P. & Stewart, D.J. Immunoreactive endothelin in human plasma: Marked elevations in patients in cardiogenic shock. Biochem. biophys. Res. Commun. 161, 562–567 (1989).
  Article CAS Google Scholar
• Yasuda, M. et al. Circulating immunoreactive endothelin in ischemic heart disease. Am. Heart J. 119, 801–806 (1990).
  Article CAS Google Scholar
• Lerman, A. et al. Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis. New Engl. J. Med. 325, 997–1001 (1991).
  Article CAS Google Scholar
• Yokokawa, K. et al. Hypertension associated with endothelin-secreting malignant hemangioendpthelioma. Ann. intern. Med. 114, 213–215 (1991).
  Article CAS Google Scholar
• Yokokawa, K. et al. Endothelin-secreting tumour. J. Cardiovasc. Pharmacol. 17, S398–S401 (1991).
  Article CAS Google Scholar
• Cacoub, P., Dorent, R., Nataf, P. & Carayon, A. Endothelin-1 in pulmonary hypertension. New Engl. J. Med. 329, 1967–1968 (1993).
  Article CAS Google Scholar
• Pittet, J.F. et al. Elevated plasma endothelin-1 concentrations are associated with the severity of illness in patients with sepsis. Ann. Surg. 213, 261–264 (1991).
  Article CAS Google Scholar
• Wei, C.M. et al. Endothelin in human congestive heart failure. Circulation 89, 1580–1586 (1994).
  Article CAS Google Scholar
• Moore, K. et al. Plasma endothelin immunoreactivity in liver disease and the hepatorenal syndrome. New Engl. J. Med. 327, 1774–1778 (1992).
  Article CAS Google Scholar
• Rolinski, B., Sadri, I., Bogner, J. & Goebel, F.D. Determination of endothelin-1 immunoreactivity in plasma, cerebrospinal fluid and urine. Res. exp. Med. 194, 9–24 (1994).
  Article CAS Google Scholar
• Nakamuta, M. et al. High plasma concentrations of endothelin-like immunoreactivities in patients with hepatocellular carcinoma. Am. J. Gastroenterol. 88, 248–252 (1993).
  CAS PubMed Google Scholar
• Moller, S., Emmeluth, C. & Henriksen, J.H. Elevated circulating plasma endothelin-1 concentrations in cirrhosis. J. Hepatol. 19, 285–290 (1993).
  Article CAS Google Scholar
• MacCumber, M.W., Ross, C.A., Glaser, B.M. & Snyder, S.H. Endothelin: Visualization of mRNAs by in situ hybridization provides evidence for local action. Proc. natn. Acad. Sci. U.S.A. 86, 7285–7289 (1989).
  Article CAS Google Scholar
• Wagner, O.F. et al. Polar secretion of endothelin-1 by cultured endothelial cells. J. biol. Chem. 267, 16066–16088 (1992).
  CAS Google Scholar
• Rubanyi, G.M. & Parker Botelho, L.H. Endothelins. FASEB J. 5, 2713–2720 (1991).
  Article CAS Google Scholar
• Warner, T.D., Battistini, B., Doherty, A.M. & Corder, R. Endothelin receptor antagonists: Actions and rationale for their development. Biochem. Pharmacol. 48, 625–635 (1994).
  Article CAS Google Scholar
• Battistini, B., D'Orleans-Juste, P. & Sirois, P. Endothelins: Circulating plasma levels and presence in other biologic fluids. Lab. Invest. 68, 600–628 (1993).
  CAS PubMed Google Scholar
• Simonson, M.S. & Dunn, M.J. Cellular signaling by peptides of the endothelin gene family. FASEB J. 4, 2989–3000 (1990).
  Article CAS Google Scholar
• Erdos, E.G., Schulz, W.W., Gafford, J.T. & Defendini, R. Neutral metalloendopeptidase in human male genital tract: Comparison to angiotensin I-converting enzyme. Lab. Invest. 52, 437–447 (1985).
  CAS PubMed Google Scholar
• Papandreou, C. et al. Loss of neutral endopeptidase in androgen independent prostate cancers. Proc. Am. Assoc. Cancer Res. 36, 268 (1995).
  Google Scholar
• Stamey, T.A. et al. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. New Engl. J. Med. 317, 909–916 (1987).
  Article CAS Google Scholar
• Oesterling, J.E. et al. Prostate-specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy. J. Urol. 139, 766–779 (1988).
  Article CAS Google Scholar
• Rubin, S.A. & Levin, E.R. The endocrinology of vasoactive peptides: Synthesis to function. J. clin. Endocr. Metabol. 78, 6–10 (1994).
  CAS Google Scholar
• Polderman, K.H. et al. Influence of sex hormones on plasma endothelin levels. Ann. intern. Med. 118, 429–432 (1993).
  Article CAS Google Scholar
• Scher, H.I. & Chung, L.W.K. Bone metastases: Improving the therapeutic index. Semin. Oncol. 21, 630–656 (1994).
  CAS PubMed Google Scholar
• Alam, A.S.M.T. et al. Endothelin inhibits osteoclastic bone resorption by a direct effect on cell motility: Implications for the vascular control of bone resorption. Endocrinology 130, 3617–3624 (1992).
  Article CAS Google Scholar
• Charache, S. & Page, D.L. Infarction of bone marrow in the sickle cell disorders. Ann. intern. Med. 67, 1195–1200 (1967).
  Article CAS Google Scholar
• Platt, O.S. et al. Pain in sickle cell disease: Rates and risk factors. New Engl. J. Med. 325, 11–16 (1991).
  Article CAS Google Scholar
• Lam, H.C. et al. Immunoreactive endothelin in human plasma, urine, milk, and saliva. J. Cardiovasc. Pharmacol. 17, S390–393 (1991).
  Article CAS Google Scholar
• Reddi, A.H. & Huggins, C. Biochemical sequences in the transformation of normal fibroblasts in adolescent rats. Proc. natn. Acad. Sci. U.S.A. 69, 1601–1605 (1972).
  Article CAS Google Scholar
• Reddi, A.H. & Sullivan, N.E. Matrix-induced endochondral bone differentiation influence of hypophysectomy, growth hormone, and thyroid-stimulating hormone. Endocrinology 107, 1291–1299 (1980).
  Article CAS Google Scholar
• Lowry, O.H., Rosebrough, N.J., Farr, A.L. & Randall, R.J. Protein measurement with the Folin phenol reagent. J. biol. Chem. 193, 265 (1951).
  CAS Google Scholar
• Kramer, C.Y. Extension of multiple range tests to group means with unequal numbers of replications. Biometrics 12, 307–310 (1956).
  Article Google Scholar
• Kruskal, W.H. & Wallis, W.A. Use of ranks in one-criterion variance analysis. J. Am. Stat. Assoc. 47, 583–621 (1952). Addendum, ibid. 48, 907–911 (1953).
  Article Google Scholar